Cite
MLA Citation
Xiao X. Wei et al.. “A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone‐ and/or Enzalutamide‐Refractory Metastatic Castration‐Resistant Prostate Cancer.” Oncologist, vol. 23, 2018, pp. 656–e64. http://access.bl.uk/ark:/81055/vdc_100066471096.0x00002f